Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune responses induced by different vaccine platforms against coronavirus disease-19
Eknath D. Ahire, Sanjay J. Kshirsagar
Exploration of Immunology (2021), pp. 243-257
Open Access | Times Cited: 8

Showing 8 citing articles:

Protein Engineering: A Novel Approach in Vaccine Development
Diwas Adhikari, Sharada Pokhrel
Journal of Drug Delivery and Therapeutics (2025) Vol. 15, Iss. 2, pp. 137-142
Open Access
Ferritin nanocages as efficient nanocarriers and promising platforms for COVID-19 and other vaccines development
Aliaksandra A. Reutovich, Ayush Srivastava, Paolo Arosio, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2022) Vol. 1867, Iss. 3, pp. 130288-130288
Open Access | Times Cited: 18
Impact of Protein Nanoparticle Shape on the Immunogenicity of Antimicrobial Glycoconjugate Vaccines
Marta Dolce, Daniela Proietti, Silvia Principato, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3736-3736
Open Access | Times Cited: 2
Innovations in mRNA-based cancer immunotherapy: Challenges and future directions
Matthew Essuah, Buniechukwuenu Emmanuel Mbamalu, Ridwan Ayodele Akanmu, et al.
World Journal of Biology Pharmacy and Health Sciences (2024) Vol. 20, Iss. 2, pp. 702-724
Open Access
Development, Pre-Clinical Safety, and Immune Profile of RENOVAC—A Dimer RBD-Based Anti-Coronavirus Subunit Vaccine
Muzaffar Muminov, Nargiza A. Tsiferova, Egor Pshenichnov, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1420-1420
Open Access
Can interventions targeting MDSCs improve the outcome of vaccination in vulnerable populations?
Yuliya V. Perfilyeva, Arthur Aquino, M Borodin, et al.
International Reviews of Immunology (2024), pp. 1-17
Closed Access
Designing a Vaccine Platform composed of Phage encapsulated with Chitosan Nanoparticles Targeting Pathogenic Viruses
Faten Mohammed Mahdi Shukur
JOURNAL OF COMMUNICABLE DISEASES (2023) Vol. 55, Iss. 02, pp. 9-17
Open Access | Times Cited: 1
Aspects and issues of marketing authorisation and use of medicinal products for COVID-19 prevention during the pandemic
А. А. Солдатов, Д. В. Горенков, В. А. Меркулов, et al.
Biological Products Prevention Diagnosis Treatment (2022) Vol. 22, Iss. 4, pp. 361-381
Open Access | Times Cited: 2
Page 1

Scroll to top